Cargando…
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
BACKGROUND: A previous analysis of 113 National Comprehensive Cancer Network(®) (NCCN(®)) recommendations reported that NCCN frequently recommends beyond Food and Drug Administration (FDA)-approved indications (44 off-label recommendations) and claimed that the evidence for these recommendations was...
Autores principales: | Kurzrock, R, Gurski, L A, Carlson, R W, Ettinger, D S, Horwitz, S M, Kumar, S K, Million, L, von Mehren, M, Benson, A B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857604/ https://www.ncbi.nlm.nih.gov/pubmed/31373348 http://dx.doi.org/10.1093/annonc/mdz232 |
Ejemplares similares
-
Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines
por: Noy, Miguel Angel, et al.
Publicado: (2021) -
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
por: Vaddepally, Raju K., et al.
Publicado: (2020) -
Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022
por: Arboleda, Lady Paola Aristizabal, et al.
Publicado: (2023) -
The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO
por: Kim, Young Zoon, et al.
Publicado: (2022) -
Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study
por: Wagner, Jeffrey, et al.
Publicado: (2018)